ABL80 FLEX ANALYZER
Report
- Report Number
- 2027541-2009-00017
- Event Type
- Injury
- Date Received
- December 1, 2009
- Date of Event
- November 1, 2009
- Report Date
- November 2, 2009
- Manufacturer
- SENDX MEDICAL, INC.
- Product Code
- CHL
- PMA / PMN Number
- K051804
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- DA
- Reporter Occupation
- OTHER
Narratives
REQUESTS WERE MADE FOR ADDITIONAL DETAILS ABOUT THE INCIDENT. IT IS UNK IF FURTHER MEDICAL INTERVENTION WAS REQUIRED. ONE RESPONSE INDICATED THAT THE CLINICAL PICTURE DID NOT MEASURE UP WITH A POTASSIUM VALUE OF 8.0 MMOL/L. DEVICE LABELING (LIMITATIONS OF USE IN THE OPERATOR'S MANUAL) STATES THAT THE VALIDITY OF THE TEST RESULTS FROM THIS INSTRUMENT MUST BE CAREFULLY EXAMINED BY A CLINICIAN AND RELATED TO THE PT'S CLINICAL CONDITION, BEFORE ANY CLINICAL DECISION IS TAKEN ON THE BASIS OF THE TEST RESULTS. IT IS POSSIBLE THAT SAMPLE HANDLING LEAD TO THE ELEVATED VALUE OF 8.0 MMOL/L. A SMALL BUBBLE LODGED DIRECTLY OVER A SENSOR COULD HAVE CAUSED THE REPORTED EXPERIENCE. THE REFERENCE RANGE FOR POTASSIUM FOR ADULTS' ARTERIAL BLOOD IS 3.4 - 4.5 MMOL/L. DATA LOGS FROM THE ANALYZER IN QUESTION WERE REVIEWED. THE ANALYZER APPEARS TO HAVE BEEN FUNCTIONING WELL AND WITHIN SPECIFICATIONS AT THE TIME OF THE INCIDENT.
IN 2009, A DISTRIBUTOR REPORTED A PROBLEM WHERE THE ABL80 FLEX ANALYZER MEASURED A POTASSIUM VALUE OF 8.0 MMOL/L. BASED ON THIS RESULT, THE PT WAS TREATED WITH RESONIUM AND I.V. SOLUTION WITH 5% GLUCOSE + 20IE ACT. AFTER ABOUT TEN (10) MINUTES, ANOTHER SAMPLE WAS DRAWN AND MEASURED BOTH ON THE ABL80 AND ON A ABL700. THE POTASSIUM RESULT WAS 3.2 MMOL/L. THE TREATMENT WAS STOPPED IMMEDIATELY, BUT THE PT HAD RECEIVED ABOUT 300 ML OF THE FLUID. THE INCIDENT WAS REPORTED TO THE HOSPITAL RISK MGR.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ABL80 FLEX ANALYZER | PH, BLOODGAS, ELECTROLYTE ANALYSIS SYSTEM | CHL | SENDX MEDICAL, INC. | 393-839 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |